InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,564.47
(
1.08%
)
US TECH 100
19,299.20
(
1.52%
)
Dow Jones
40,363.09
(
0.19%
)
Brent Oil
81.50
(
-0.95%
)
Bitcoin
67,488.49
(
-0.98%
)
Post# of 8172
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Crusader

Send PM Follow Ignore
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Crusader

Re: None

Tuesday, 10/10/2017 11:09:42 AM

Tuesday, October 10, 2017 11:09:42 AM

Post# of 8172
FROM TODAY's PR:


..."To date, the PDC molecules have demonstrated a clear cancer targeting advantage over the unconjugated payloads," said Jim Caruso, president and CEO of Cellectar Biosciences. "We look forward to leveraging the synergistic technologies and skills of our respective organizations to further advance this exciting research...."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CLRB News
More CLRB News
InvestorsHub NewsWire

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!